A noninvasive brain stimulation technique can relieve symptoms of subclinical depression in adults, scientists present liver-targeted therapies that can rescue inherited metabolic disorders in mice, and more this week in #ScienceTranslationalMedicine. scim.ag/4zUwAIz
A new clinical trial tests a combo of #osimertinib, platinum and etoposide chemotherapy in patients with EGFR-mutant #LungCancer, and reveals how lineage plasticity shapes the risk of #SCLC transformation and drug resistance. @jmchan88 @MSKCancerCenter scim.ag/4ewEoYg
Science Translational Medicine retweeted
Excited that our @ScienceTM manuscript was published this week. Great work Andrew Haddad (1st author) in my lab and the entire @AllofUsResearch team.
In ~100k participants with linked WGS and EHR data, EVERY participant carried a #PGx variant in just 16 genes and nearly all had potentially actionable findings where there is a @cpicpgx guideline or FDA labeling recommending a change in prescribing. ~24% had already been exposed to impacted drug. We also reported allele, diplotype, and predicted phenotype frequencies and identified >17k novel variants.
Article➡️
science.org/doi/10.1126/scit…
More info➡️bit.ly/4fsla6m
@pittpharmacy @iPrecisionMed @PittHealthSci @UPMCnews
Science Translational Medicine retweeted
¡Buenos días!
No todos los sábados te despiertas viendo tu nombre junto al de grandes colegas y científicos en @ScienceTM de @ScienceMagazine .
Gracias a otra fructífera colaboración liderada por @BernasconiFosco , de @OlafBlankeLab , seguimos aportando desde @UtmSantPau nuevos conocimientos sobre las alucinaciones visuales en la enfermedad de Parkinson.
science.org/doi/10.1126/scit…
Sleep-like slow brain waves are more frequent in patients with #ParkinsonsDisease and correlate with a greater hallucination burden and poorer cognitive function, according to a new EEG analysis of patients. @OlafBlankeLab @BernasconiFosco @Neuro_X_EPFL scim.ag/489CGIP
4
673
By analyzing a massive collection of #TcellReceptor chains from 150,000+ patient samples, researchers develop a pipeline to accelerate the discovery and validation of public T cell receptors for immunotherapeutic design. @BioNTech_Group scim.ag/48BezCN
A new drug screening study identifies the approved blood thinner #dabigatran as a potent #osteoarthritis treatment in large animals, showing that it can inhibit both TNF-alpha and IL-1-beta through the protein BIG2 and dampen inflammation. @OrthoAtYale scim.ag/3WF6bj4
485
A #pharmacogenomics analysis of 100,000 participants in the @AllofUsResearch program sheds light on the landscape of pharmacogene variants in diverse ancestries and tackles gaps in genomics knowledge in underrepresented groups. @philempey @pittpharmacy scim.ag/4t0sL1S
A study of 100,000 diverse Americans tackles gaps in pharmacogenomics representation, scientists connect sleep-like slow brain waves to hallucinations and poorer cognition in Parkinson’s disease, and more this week in #ScienceTranslationalMedicine. scim.ag/48Lwery
By comparing PET scans between patients with early-onset and late-onset #AlzheimersDisease, researchers uncover key differences in tauopathy between the age groups that could inform future diagnostics and therapeutics. @UCSFmac scim.ag/4z9byVl
How well does #VRC01 protect against #HIV?
An analysis of the post-infusion period in two clinical trials shows that prophylaxis blocks infections with sensitive strains but that breakthrough infections still occur after infusions stopped. @fredhutch scim.ag/4elPMWL
A triplet combination therapy based on first-line #regorafenib remodels the tumor microenvironment in patients with advanced #GastricCancer while displaying promising safety and response rate, according to a new phase 2 clinical trial. @NccriOfficial scim.ag/4Agt1vJ
In a unique human challenge study, researchers interrogate how preexisting immunity and antibodies against the four serotypes of #dengue influence viremia, T cell responses, and immune activation in a safe and controlled setting. @CamilaOdio @NIH scim.ag/3W4jxVS
By analyzing a massive collection of #TcellReceptor chains from 150,000+ patient samples, researchers develop a pipeline to accelerate the discovery and validation of public T cell receptors for immunotherapeutic design. @BioNTech_Group scim.ag/48BezCN
Clinical trials of an anti-HIV antibody offer clues to prevent viral escape and resistance, a massive dataset accelerates the discovery of T cell receptors for future cancer therapeutics, and more this week in #ScienceTranslationalMedicine. scim.ag/4sGXxwj
A new analysis of mice and samples from patients with #psoriasis identifies CHI3L2 as a central driver of the condition, showing that it propels an inflammatory loop by reprogramming phospholipid metabolism in keratinocytes. @XJTU_China scim.ag/4yYjMzC
New work links synovial inflammation in #osteoarthritis to a signaling axis involving CD74 and ENO2 that reprograms macrophages into an inflammatory and metabolically active state—but shows these cells can be targeted to treat the disease in mice. scim.ag/4A4r7yx
By applying a unique polyene scaffold, researchers engineer a next-generation, broad-spectrum #antifungal that selectively targets ergosterol without binding to cholesterol, avoiding severe toxicity linked to drugs like amphotericin B. scim.ag/4yyYZSP
A new bispecific antibody targets both #CCR8 to deplete regulatory T cells and CD3 to revitalize the broader anti-tumor T cell armada. It combated multiple tumor types and potentiated immunotherapy in mice while being safe in large animals. @genentech scim.ag/4e4t05H
In a unique human challenge study, researchers interrogate how preexisting immunity and antibodies against the four serotypes of #dengue influence viremia, T cell responses, and immune activation in a safe and controlled setting. @CamilaOdio @NIH scim.ag/3W4jxVS




















